The Family Firm’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-581
| Closed | -$253K | – | 115 |
|
|
2025
Q1 | $253K | Sell |
581
-44
| -7% | -$19.1K | 0.06% | 186 |
|
|
2024
Q4 | $231K | Sell |
625
-19
| -3% | -$7.01K | 0.05% | 192 |
|
|
2024
Q3 | $335K | Buy |
644
+1
| +0.2% | +$520 | 0.07% | 154 |
|
|
2024
Q2 | $348K | Buy |
643
+2
| +0.3% | +$1.08K | 0.08% | 145 |
|
|
2024
Q1 | $333K | Buy |
641
+1
| +0.2% | +$519 | 0.08% | 148 |
|
|
2023
Q4 | $302K | Buy |
640
+17
| +3% | +$8.02K | 0.08% | 145 |
|
|
2023
Q3 | $271K | Buy |
623
+2
| +0.3% | +$871 | 0.08% | 141 |
|
|
2023
Q2 | $276K | Buy |
621
+1
| +0.2% | +$445 | 0.07% | 148 |
|
|
2023
Q1 | $285K | Buy |
620
+5
| +0.8% | +$2.3K | 0.08% | 146 |
|
|
2022
Q4 | $315K | Buy |
615
+37
| +6% | +$19K | 0.09% | 140 |
|
|
2022
Q3 | $262K | Sell |
578
-20
| -3% | -$9.07K | 0.08% | 147 |
|
|
2022
Q2 | $288K | Buy |
598
+1
| +0.2% | +$482 | 0.08% | 147 |
|
|
2022
Q1 | $293K | Buy |
597
+1
| +0.2% | +$491 | 0.08% | 144 |
|
|
2021
Q4 | $276K | Buy |
596
+1
| +0.2% | +$463 | 0.07% | 149 |
|
|
2021
Q3 | $252K | Buy |
595
+2
| +0.3% | +$847 | 0.07% | 153 |
|
|
2021
Q2 | $227K | Buy |
593
+1
| +0.2% | +$383 | 0.06% | 166 |
|
|
2021
Q1 | $213K | Buy |
+592
| New | +$213K | 0.06% | 167 |
|